 Stefanie Kennon-Mcgill
Concepts (123)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlea | 3 | 2019 | 20 | 0.970 |
Why?
| | Acetaminophen | 8 | 2023 | 350 | 0.780 |
Why?
| | Cannabidiol | 4 | 2023 | 35 | 0.730 |
Why?
| | Pharmaceutical Preparations | 1 | 2019 | 86 | 0.650 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 151 | 0.600 |
Why?
| | Plant Extracts | 4 | 2020 | 192 | 0.490 |
Why?
| | Liver | 6 | 2020 | 1226 | 0.400 |
Why?
| | Cannabis | 4 | 2023 | 149 | 0.400 |
Why?
| | Liver Regeneration | 2 | 2019 | 57 | 0.320 |
Why?
| | Alanine Transaminase | 4 | 2023 | 151 | 0.310 |
Why?
| | Drug Overdose | 3 | 2020 | 154 | 0.300 |
Why?
| | Child Development | 2 | 2018 | 204 | 0.270 |
Why?
| | Mice, Inbred C57BL | 6 | 2020 | 2002 | 0.260 |
Why?
| | Liver Diseases | 1 | 2023 | 87 | 0.220 |
Why?
| | Phosphatidic Acids | 2 | 2019 | 8 | 0.200 |
Why?
| | Mice | 7 | 2023 | 6428 | 0.200 |
Why?
| | Liver Failure, Acute | 1 | 2022 | 64 | 0.200 |
Why?
| | End Stage Liver Disease | 1 | 2022 | 44 | 0.200 |
Why?
| | Cytochrome P-450 Enzyme System | 2 | 2020 | 192 | 0.200 |
Why?
| | Animals | 11 | 2023 | 14402 | 0.200 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2021 | 140 | 0.180 |
Why?
| | Biological Transport, Active | 1 | 2019 | 35 | 0.180 |
Why?
| | Hepatic Veno-Occlusive Disease | 1 | 2019 | 10 | 0.180 |
Why?
| | Xenobiotics | 1 | 2019 | 27 | 0.170 |
Why?
| | Glycerol-3-Phosphate O-Acyltransferase | 1 | 2019 | 5 | 0.170 |
Why?
| | Sulfotransferases | 1 | 2019 | 43 | 0.170 |
Why?
| | ortho-Aminobenzoates | 1 | 2019 | 9 | 0.170 |
Why?
| | Liver Cirrhosis | 1 | 2021 | 218 | 0.170 |
Why?
| | Anti-Obesity Agents | 1 | 2019 | 22 | 0.170 |
Why?
| | Tea | 1 | 2019 | 35 | 0.170 |
Why?
| | Phosphatidate Phosphatase | 1 | 2018 | 11 | 0.160 |
Why?
| | Videotape Recording | 1 | 2018 | 29 | 0.160 |
Why?
| | Social Behavior | 1 | 2018 | 83 | 0.150 |
Why?
| | Glucuronosyltransferase | 1 | 2019 | 157 | 0.150 |
Why?
| | Fixation, Ocular | 1 | 2017 | 20 | 0.150 |
Why?
| | Sulfonamides | 1 | 2019 | 146 | 0.150 |
Why?
| | Hepatocytes | 1 | 2019 | 214 | 0.150 |
Why?
| | Kinetics | 1 | 2019 | 692 | 0.150 |
Why?
| | Face | 1 | 2017 | 66 | 0.150 |
Why?
| | Bacteria | 1 | 2019 | 257 | 0.150 |
Why?
| | Interpersonal Relations | 1 | 2017 | 115 | 0.140 |
Why?
| | Gene Expression | 1 | 2019 | 664 | 0.140 |
Why?
| | Attention | 1 | 2017 | 185 | 0.140 |
Why?
| | Nuclear Proteins | 1 | 2018 | 253 | 0.140 |
Why?
| | Communication | 1 | 2018 | 265 | 0.140 |
Why?
| | Hair Cells, Auditory | 1 | 2015 | 5 | 0.140 |
Why?
| | Sound | 1 | 2015 | 11 | 0.140 |
Why?
| | Hearing | 1 | 2016 | 59 | 0.140 |
Why?
| | Autistic Disorder | 1 | 2017 | 135 | 0.130 |
Why?
| | Hearing Loss, Noise-Induced | 1 | 2015 | 9 | 0.130 |
Why?
| | Signal Transduction | 2 | 2022 | 1751 | 0.130 |
Why?
| | Oxidative Stress | 2 | 2023 | 956 | 0.130 |
Why?
| | Male | 10 | 2021 | 27335 | 0.100 |
Why?
| | Infant | 3 | 2023 | 3832 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2019 | 1476 | 0.070 |
Why?
| | Female | 6 | 2023 | 28457 | 0.060 |
Why?
| | Alanine | 1 | 2023 | 44 | 0.060 |
Why?
| | Pyruvic Acid | 1 | 2023 | 24 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2019 | 1651 | 0.060 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2022 | 79 | 0.050 |
Why?
| | Glutathione | 1 | 2023 | 330 | 0.050 |
Why?
| | Oxidation-Reduction | 1 | 2023 | 383 | 0.050 |
Why?
| | Humans | 7 | 2023 | 54304 | 0.050 |
Why?
| | Glutamate Dehydrogenase | 1 | 2021 | 15 | 0.050 |
Why?
| | HMGB1 Protein | 1 | 2021 | 17 | 0.050 |
Why?
| | Keratin-18 | 1 | 2021 | 15 | 0.050 |
Why?
| | Antioxidants | 1 | 2023 | 297 | 0.050 |
Why?
| | Taurine | 1 | 2020 | 16 | 0.050 |
Why?
| | Rats | 2 | 2020 | 3417 | 0.050 |
Why?
| | Herb-Drug Interactions | 1 | 2020 | 30 | 0.050 |
Why?
| | Drug Administration Schedule | 1 | 2021 | 401 | 0.050 |
Why?
| | Toxicity Tests | 1 | 2020 | 52 | 0.050 |
Why?
| | Alkaline Phosphatase | 1 | 2020 | 99 | 0.050 |
Why?
| | Adenosylhomocysteinase | 1 | 2020 | 11 | 0.050 |
Why?
| | Alcohol Dehydrogenase | 1 | 2020 | 31 | 0.050 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2020 | 27 | 0.050 |
Why?
| | Young Adult | 2 | 2021 | 4313 | 0.040 |
Why?
| | Glutamine | 1 | 2020 | 168 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2020 | 237 | 0.040 |
Why?
| | Liver Function Tests | 1 | 2019 | 43 | 0.040 |
Why?
| | Proteomics | 1 | 2022 | 343 | 0.040 |
Why?
| | Thinness | 1 | 2019 | 57 | 0.040 |
Why?
| | Mice, Inbred Strains | 1 | 2019 | 199 | 0.040 |
Why?
| | Drug Synergism | 1 | 2019 | 171 | 0.040 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2019 | 82 | 0.040 |
Why?
| | Child, Preschool | 2 | 2018 | 4161 | 0.040 |
Why?
| | Pilot Projects | 1 | 2021 | 805 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2022 | 1083 | 0.040 |
Why?
| | Necrosis | 1 | 2019 | 208 | 0.040 |
Why?
| | beta Catenin | 1 | 2019 | 102 | 0.040 |
Why?
| | Twins, Dizygotic | 1 | 2017 | 7 | 0.040 |
Why?
| | Endophenotypes | 1 | 2017 | 7 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2018 | 85 | 0.040 |
Why?
| | Twins, Monozygotic | 1 | 2017 | 18 | 0.040 |
Why?
| | Dexamethasone | 1 | 2020 | 435 | 0.040 |
Why?
| | Eye | 1 | 2017 | 36 | 0.040 |
Why?
| | Siblings | 1 | 2017 | 38 | 0.040 |
Why?
| | Mouth | 1 | 2017 | 35 | 0.040 |
Why?
| | Phosphorylation | 1 | 2019 | 613 | 0.040 |
Why?
| | Dietary Supplements | 1 | 2020 | 452 | 0.040 |
Why?
| | Transcriptome | 1 | 2019 | 346 | 0.040 |
Why?
| | Prognosis | 1 | 2022 | 2126 | 0.040 |
Why?
| | Glutathione Disulfide | 1 | 2016 | 45 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2019 | 445 | 0.030 |
Why?
| | Hair Cells, Auditory, Inner | 1 | 2015 | 1 | 0.030 |
Why?
| | Hair Cells, Auditory, Outer | 1 | 2015 | 1 | 0.030 |
Why?
| | Tissue Preservation | 1 | 2015 | 9 | 0.030 |
Why?
| | Rats, Long-Evans | 1 | 2015 | 29 | 0.030 |
Why?
| | Plastics | 1 | 2015 | 13 | 0.030 |
Why?
| | Noise | 1 | 2015 | 37 | 0.030 |
Why?
| | Auditory Threshold | 1 | 2015 | 46 | 0.030 |
Why?
| | Pregnancy | 1 | 2023 | 2637 | 0.030 |
Why?
| | Prospective Studies | 1 | 2021 | 2604 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2019 | 1097 | 0.030 |
Why?
| | Middle Aged | 2 | 2021 | 13076 | 0.030 |
Why?
| | Risk Assessment | 1 | 2019 | 1361 | 0.030 |
Why?
| | Protein Binding | 1 | 2016 | 736 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1141 | 0.030 |
Why?
| | Adult | 2 | 2021 | 14189 | 0.030 |
Why?
| | United States | 1 | 2023 | 5204 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2015 | 1294 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2018 | 3430 | 0.020 |
Why?
| | Aged | 1 | 2018 | 10054 | 0.010 |
Why?
|
|
Kennon-Mcgill's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|